MISSION
Mirum Pharmaceuticals is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. We are passionate about advancing scientific discoveries to become important medicines for rare disease patients. We are collaborative, creative, and experienced professionals and we’re looking to augment our team with other individuals who embody our values: care, be real, get it done, and have fun, seriously.
POSITION SUMMARY
The AD of Strategic Engagements, a field-based member of the Marketing Team, serves as a key strategic partner between Mirum Pharmaceuticals and the healthcare community, focusing on cultivating and maintaining relationships with key opinion leaders (KOLs), thought leaders, and other external stakeholders. This role is responsible for building scientific credibility, supporting brand strategy, and ensuring aligned, compliant engagement with external experts to enhance awareness and education. Area of focus will largely be supporting the Genetics, Endocrinology, Metabolics (GEM) Team at Mirum.
JOB FUNCTIONS/RESPONSIBILITIES
- States likely to be included in territory include: Western half of the United States
- Develop and communicate the strategic vision and operational plan for engaging KOLs.
- Develop and oversee development and execution of individual KOL Mapping KOLs plans.
- Partner closely with the Director, Marketing for the GEM Brands at Mirum
- Build and maintain productive, collaborative, and compliant relationships with peers leading teams in Marketing, Market Access, Patient Services, and Medical Affairs.
- Work closely with the Field Sales team on the execution of all thought leader-related initiatives and programs.
- Build mechanisms to collect insights, synthesize and integrate them, and communicate to brand to inform tactics
- Bring thought leaders closer to Mirum by ensuring compliant, value-added connections across the organization.
- Collaborate with Medical Leadership on engagement strategy and planning as appropriate, including support and coordination of commercial advisory boards.
- Engage with KOLs to solicit feedback that shapes and informs brand strategy.
- Contribute Marketing strategy for conferences/congresses including sponsorships, communication/messaging, and advocacy group engagement.
- Work in partnership with the Marketing portfolio leaders and field leadership to develop appropriate KPIs and metrics to support the brand marketing and executional goals.
- Act as primary point of contact for the field, maintaining an effective two-way dialogue on KOL engagement, potential speaker identification, and up-and-coming thought leaders and experts.
- Analyze market data, confirm data reliability and inform team stakeholders to make informed decisions.
- Proactively engage partners in Legal and Compliance to ensure programs and processes are being delivered with the highest ethical standards
QUALIFICATIONS
Education/Experience:
- Bachelor’s degree (required)
- A minimum of 6 years of pharmaceutical or related industry experience required, mostly in a customer-facing capacity
- A minimum of 3 years of working with Genetics and/or Endocrinology KOLs preferred
- A minimum of 2 years of working in a cross-collaboration, matrix environment preferred
- Will otherwise consider healthcare providers (genetic counselors, APPs) with at least 3-5 years of experience in genetics and/or endocrinology
Knowledge, Skills and Abilities:
- Strategic thinking and an ability to work in a hands-on manner to deliver on multiple priorities
- Able to draw insights from a variety of sources, understands market and competition.
- Compiles relevant data from appropriate sources and performs analysis.
- Positively minded, with the ability to build lasting relationships with all types of personalities. Outgoing personalities are a must for this role.
- Experience working successfully within a cross collaborative internal environment.
- Synthesize complex and diverse information, recognizes trends and/or interrelationship.
- Ability to meet objectives and deadlines, promote efficiency and effectiveness, and incorporate improvements and program return on investment (ROI).
- Strong project management experience and the ability to manage and coordinate projects with multiple internal stakeholders and vendors on time
- Excellent verbal, written, organization and interpersonal skills required.
- Versed in MS Office tools including Word, PowerPoint, and Outlook.
Travel Requirements
- Approximately 65% of domestic travel throughout the US. Selected candidate must live near a major airport and be able to travel regularly throughout the assigned area and attend meetings at both Mirum office and off-site locations through the US.
#LI-REMOTE
Mirum Pharmaceuticals is committed to Equal Employment Opportunity (EEO) and to compliance with all Federal, State and Local laws that prohibit employment discrimination on the basis of race, age, national origin, ethnicity, religion, gender, gender identity, pregnancy, marital status, sexual orientation, citizenship, genetic disposition or characteristics, disability, veteran’s status or any other classification protected by applicable State/Federal/Local laws.
Mirum Pharmaceuticals provides reasonable accommodation for qualified individuals with disabilities and disabled veterans in job application procedures.
Skills Required
- Bachelor's degree
- At least 6 years of pharmaceutical or related industry experience, primarily in a customer-facing capacity
- At least 3 years working with Genetics and/or Endocrinology key opinion leaders
- At least 2 years working in a cross-collaboration, matrix environment
- Healthcare providers such as genetic counselors or advanced practice providers with at least 3–5 years of genetics and/or endocrinology experience may be considered
- Strategic thinking and ability to manage multiple priorities hands-on
- Ability to analyze market data, synthesize complex information, and identify trends
- Strong relationship-building, communication, organizational, and interpersonal skills
- Strong project management and coordination experience with internal stakeholders and vendors
- Proficiency with Microsoft Office tools, including Word, PowerPoint, and Outlook
- Ability to travel approximately 65% domestically and live near a major airport
Mirum Pharmaceuticals Compensation & Benefits Highlights
The following summarizes recurring compensation and benefits themes identified from responses generated by popular LLMs to common candidate questions about Mirum Pharmaceuticals and has not been reviewed or approved by Mirum Pharmaceuticals.
-
Equity Value & Accessibility — Equity grants to new hires and an employee stock purchase plan make ownership more accessible and can boost total rewards when performance is strong. Public disclosures highlight frequent option/RSU inducements.
-
Healthcare Strength — Comprehensive medical, dental, and vision coverage is employer-paid for employees, with added life, disability, and EAP support. This combination reduces financial burden and enhances overall wellbeing.
-
Leave & Time Off Breadth — A broad time-off program includes multiple paid company holidays, a year-end shutdown, accrued vacation, and paid parental leave. This breadth provides additional rest periods beyond standard vacation.
Mirum Pharmaceuticals Insights
What We Do
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases. Mirum’s approved medication is LIVMARLI® (maralixibat) oral solution which is approved in the U.S. for the treatment of cholestatic pruritus in patients with Alagille syndrome one year of age and older. Mirum’s late-stage pipeline includes two investigational treatments for debilitating liver diseases affecting children and adults. Maralixibat (LIVMARLI), an oral ileal bile acid transporter (IBAT) inhibitor, is currently being evaluated in clinical trials for pediatric liver diseases and includes the MARCH Phase 3 study for progressive familial intrahepatic cholestasis (PFIC) and the EMBARK Phase 2b study for patients with biliary atresia. In addition, Mirum has an expanded access program open in Canada, Australia, the UK and several countries in Europe for eligible patients with Alagille syndrome. Mirum has submitted a Marketing Authorization Application to the European Medicines Agency for maralixibat for the treatment of cholestatic liver disease in patients with Alagille syndrome. Mirum’s second investigational treatment, volixibat, also an oral IBAT inhibitor, is being evaluated in three potentially registrational studies including the OHANA Phase 2b study for pregnant women with intrahepatic cholestasis of pregnancy, VISTAS Phase 2b study for adults with primary sclerosing cholangitis, and the VANTAGE Phase 2b study for primary biliary cholangitis.
